VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1522168
Sex: F
Age:
State: IL

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: felt very weak; felt dizzy; nauseous; Laid down and couldnt even move head as room was spinning.; vomited; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 09:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no allergies to medications, food or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 12:30, after 2 hours of vaccination, the patient felt dizzy and nauseous. The patient did lie down and couldn't even move her head as room was spinning. The patient tried to get up but made her more nauseous and vomited. The patient stayed in bed all day and at and the next day on 28Mar2021, the patient still had little nausea and felt very weak. By evening the patient was able to eat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events dizziness and nausea which included treatment with DRAMAMINE. No therapeutic measures were taken as a result of the events head spinning, vomited and felt very weak. The clinical outcomes of the events dizzy, nauseous, laid down and couldn't even move the head as room was spinning, vomited and felt very weak was recovered on an unknown date in Mar2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1522169
Sex: F
Age:
State: CA

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: severe chest pain that would come and go every 20-30 minutes in sharp increments; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 at 10:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Mar2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 10:45, 24 hours after receiving the second dose of vaccine, the patient experienced severe chest pain that would come and go every 20-30 minutes in sharp increments. That lasted about 7 to 8 hours. The pain was concentrated in the middle of the patient's chest. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event severe chest pain that would come and go every 20-30 minutes in sharp increments. The clinical outcome of the event severe chest pain that would come and go every 20-30 minutes in sharp increments was resolved on 06Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522170
Sex: F
Age:
State: CT

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Headache; joint pain; chills; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 06Apr2021 at 16:30(at the age of 64-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to medications, food, or other products. Concomitant medications were not included. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 06Apr2021 at 16:30, the patient experienced headache, joint pain and chills. On the other hand, the patient thought that way more than 4% of those vaccinated experience a little something, should not be afraid if feel something. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, joint pain and chills was recovering. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522171
Sex: F
Age:
State: TX

Vax Date: 03/10/2021
Onset Date:
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Herpes simplex 1; Fever; Blister in nose; This is a spontaneous report from a contactable other health care professsional. A 40-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 10Mar2021 at 13:45 (Age at vaccination: 40 years) as dose 1, single for covid-19 immunization. Medical history was None. Concomitant medications included ESTRADIOL patch 0.75. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced herpes simplex 1, fever and blister in nose on an unknown date. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The outcome of the events was recovering. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ESTRADIOL

Current Illness:

ID: 1522172
Sex: F
Age:
State: WA

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: chills; face, neck and head are itchy; red rash on back head and face; Bad arm pain to touch; cold; minor arm redness/swelling at shot site; minor arm redness/swelling at shot site; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 06Apr2021 at 12:45 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, blood pressure high and overweight. The patient was allergic to pets, latex, alcohol, skin products and seasonal allergy. The patient previously received sulfadiazine (SULFA) on an unspecified date for an unspecified indication and experienced drug allergy. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) 7.5 mg. Prior to the vaccination, the patient was diagnosed with COVID-19 was unknown. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 18:30, the patient experienced chills, face, neck and head are itchy, red rash on back head and face, bad arm pain to touch, vaccination site erythema, vaccination site swelling and cold. The patient reported in order of occurrence, chills, face and neck hot and itchy, red rash on face, back itchy, red rash across back, head itchy. The patient could not tell if it was rash. She experienced bad arm pain to touch, not usual shot arm pain, the patient could not lay on left side to sleep. She felt cold all night, used 2 blankets instead of usual 1; fitful sleep. As of this writing: arm pain was better but minor arm redness/swelling at shot site; face and neck hot; neck/back/head itchy, rash on neck/back but not as red as yesterday; felt cold. No therapeutic measures were taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events chills, itchy, red rash, pain in arm, vaccination site erythema, vaccination site swelling and cold were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: AMLODIPINE

Current Illness:

ID: 1522173
Sex: F
Age:
State: VA

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Fatigue; Pain at injection site; Joint soreness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 06Apr2021 at 17:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and had no known allergies to food, medications and other products. Concomitant medications included birth control medication (unspecified). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 19:00, the patient experienced fatigue, pain at injection site, joint soreness and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fatigue, pain at injection site, joint soreness and headache was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522174
Sex: M
Age:
State: CA

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Metal taste in mouth; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 14:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have allergy to any medications, food, or other products. The patient did not take any medications within two weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:15 the patient experienced metal taste in mouth. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event metal taste in mouth was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522175
Sex: F
Age:
State: VA

Vax Date: 03/30/2021
Onset Date: 04/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Rash on right hip; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration on 30Mar2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to penicillin (MANUFACTURER UNKNOWN). Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), from an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01Apr2021, the patient experienced rash on right hip. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of rash on right hip was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE

Current Illness:

ID: 1522176
Sex: M
Age:
State:

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Muscle soreness at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 19:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension from an unknown date. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 11:00, the patient experienced muscle soreness at injection site that lasted approx. 24 hours. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event muscle soreness at injection site was recovered on an unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ATORVASTATIN; LISINOPRIL

Current Illness:

ID: 1522177
Sex: M
Age:
State: MD

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Mouth ulcerations; mouth swelling; General body aches; Sore throat; Fever of 102,8; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 12:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history and no allergies to medications, food, or other products. Patient did not received any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient's body temperature was measured as 102.8 with unspecified units. On 05Apr2021, the patient underwent nasal swab test and the result was negative. On 25Mar2021 at 06:00, the patient had fever of 102.8, mouth ulcerations and swelling, general body aches, sore throat. This was still presented 8 days post vaccination. The patient went to emergency department on 04May2021 due to mouth swelling and ulcerations and fever. The adverse events also resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the adverse events and included treatment with antibiotic, lidocaine mouthwash (MANUFACTURER UNKNOWN) and ibuprofen (ADVIL) 600 mg on an unknown dates. The clinical outcome of the events of fever, mouth ulceration, mouth swelling, general body aches and sore throat was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522178
Sex: M
Age:
State: PA

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Cold sensation down arm below elbow to hand (by thumb).; Burning sensation down arm below elbow to hand (by thumb); This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient did not have any known allergies to medications, food or other products. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 11:15, the patient experienced cold and burning sensation down arm below elbow to hand (by thumb). The patient reported that this occurred on and off for about 20-30 minutes after and was first felt 20 minutes after the injection. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event cold and burning sensation down arm below elbow to hand (by thumb). The clinical outcomes of the events cold and burning sensation down arm below elbow to hand (by thumb) was resolved on 08Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522179
Sex: F
Age:
State: CA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Later tingly/numb feeling hand, arm, neck, face (left side); Within 15 minutes tingly hand, later tingly/numb feeling hand, arm, neck, face (left side); This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 02Apr2021 at 14:45 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), withania somnifera (ASHWAGANDHA), fish oil (MANUFACTURER UNKNOWN) and mentha x piperita oil (PEPPERMINT OIL), all from unknown date for unknown indication taken within 2 weeks of vaccination. The patient previously took naproxen (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 within 15 minutes of vaccination, at 15:00 the patient experienced tingly hand. Later, on 02Apr2021 at 15:15 the patient experienced tingly/numb feeling hand, arm, neck and face (left side).No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event tingly hand(Paraesthesia) and tingly/numb feeling hand, arm, neck, face on left side (Hypoesthesia) were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ASHWAGANDHA; FISH OIL; Peppermint oil

Current Illness:

ID: 1522180
Sex: M
Age:
State: CA

Vax Date: 03/12/2021
Onset Date: 03/24/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Swelling of the palate; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 11:00 (at the age of 60-year-old) as a single dose and also received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 02Apr2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to penicillin. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 24Mar2021, the patient had experienced swelling of the palate. The patient did not receive any treatment for the reported event. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swelling of the palate was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522181
Sex: F
Age:
State: AL

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Feeling/sensation in upper arm below injection site. (Not painful); A painful and uncomfortable feeling went into the middle finger of same arm .; A painful and uncomfortable feeling in joint of same arm; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 26Mar2021 at 15:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not provided. The patient had no known allergies to medications, food, or other products. Concomitant medication included celecoxib (CELEBREX) taken for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Mar2021 at 15:45, within 30 min of receiving the shot, the patient reported that as she was driving home, she experienced a feeling/sensation in her upper arm below injection site which was not painful. The patient reported that the feeling then went into her middle finger/ joint of the same arm, it was a painful and uncomfortable feeling. The pain increased throughout the remainder of the day. The patient reported that the pain in the joint did not seem to subside even after she iced her finger. The patient still had terrible pain in the joint on that day (at the time of reporting). She had been icing as much as possible. The event resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of pain in joint and middle finger and included icing the finger and joint. The clinical outcome of the event feeling/sensation in the upper arm below injection site which was not painful and pain in joint and middle finger was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CELEBREX

Current Illness:

ID: 1522182
Sex: M
Age:
State: FL

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Headache; Body Cramps; Fever; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 08:45 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included fruit allergy towards mango. The patient did not receive any other concomitant medications within 2 weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 16Mar2021 at 08:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 23:00, the patient experienced headaches, body cramps, fever, chills and fatigue. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, body cramps, fever, chills and fatigue was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522183
Sex: F
Age:
State:

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Feels like my throat is falling asleep like when eat ginger; This is a spontaneous report from a contactable pharmacist. A 27-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via intramuscular route of administration in the right arm on 17Mar2021(at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, type 2 diabetes mellitus, and COVID 19. It was unknown if patient was pregnant at the time of vaccination. Concomitant medications included metformin hydrochloride (METFORMIN), lisinopril (MANUFACTURER UNKNOWN) and hydrochlorothiazide (HCTZ); all from unknown date and for unknown indication. The patient was allergic to ibuprofen (MOTRIN) and ginger. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received tetanus vaccine toxoid, diphtheria vaccine toxoid, pertussis vaccine acellular 3-component (BOOSTRIX) on 03Mar2021 within four weeks prior to the COVID vaccine. On 17Mar2021, the patient experienced throat felt asleep like when she ate ginger. Therapeutic measures were taken as a result of event and included treatment with BENADRYL 50mg capsule. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event throat felt asleep when she ate ginger was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; LISINOPRIL; HCTZ

Current Illness:

ID: 1522184
Sex: M
Age:
State: IN

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Chills; 102 degrees temperature; Lethargic; Achy; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 06Apr2021 at 19:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Concomitant medications were not reported. The patient did not receive any other medications within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient body temperature was measured and the result was 102 degrees. On 07Apr2021 at 00:00, the patient experienced chills, 102 degrees temperature, lethargic and achy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event chills ,102 degrees temperature, lethargic and achy was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522185
Sex: F
Age:
State: NV

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Headache; Extreme tiredness; Felt dizzy; Chills; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The relevant medical history was not reported. The patient had known allergies to sulfa (sulfonamide). Concomitant medications included fluoxetine hydrochloride (PROZAC), diazepam (MANUFACTURER UNKNOWN), eleutherococcus senticosus root (GINSENG), docosahexaenoic acid, eicosapentaenoic acid, tocopherol (OMEGA 3) and Multivitamins from on an unknown date, for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 15:00 i.e. 2 hours after the vaccination, the patient felt dizzy, out of it and chills. Fine for a week i.e. On 24Mar2021, patient experienced extreme tiredness, hard to exercise and headache. stop happening 3 weeks later. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the event felt dizzy and chills was recovered on an unknown date in Mar2021. The clinical outcome of extreme tiredness, hard to exercise and headache was recovered (stop happening 3 weeks later) i.e. on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: PROZAC; DIAZEPAM; Ginseng; Omega 3

Current Illness:

ID: 1522186
Sex: F
Age:
State: MA

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Hives on lower trunk; Vaccination site pain; Fatigue; Headache; Chills; Body aches; Fever 99.4; Nausea; General malaise; Brain fog; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 03Apr2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included controlled depression, anxiety, COVID-19 and mildly intolerant to gluten. Patient was allergic to ibuprofen (MOTRIN). Concomitant medications included escitalopram (MANUFACTURER UNKNOWN) 15mg and ethinylestradiol, drospirenone (NIKKI); both from an unknown date and for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03Apr2021 at 20:00, the patient experienced hives on lower trunk and extremities continuing 96 hours after administered, injection site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 03Apr2021, the patient body temperature was measured and the result was 99.4 (units unspecified). The clinical outcome of the event hives on lower trunk, vaccination site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, swollen lymph nodes were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ESCITALOPRAM; NIKKI

Current Illness:

ID: 1522187
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/03/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Not under her arm was sore but down the vaccination site; Couldn't breath; Legs could not hardly walk; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (Reporter's mother). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing she had Covid. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced not under her arm was sore but down the vaccination site, could not breathe, legs could not hardly walk. It was reported that reporter's mother (consumer), took Pfizer the shot yesterday and she had Covid already, but she had it in October, she still has a little bit of side effects with it, she said that under her arm was sore and she was having little bit of could not breath and her legs could not hardly walk. When paraphrased the concern, reporter stated, Yes, she said under her arm like down on the side, sore, not her arm but down the site of her the (vaccination) site where shot was. The outcome of the events were reported as unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522188
Sex: F
Age:
State: MN

Vax Date: 04/05/2021
Onset Date: 04/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Heart racing and pounding; light headed; felt really hot; This is a spontaneous report received from contactable female consumer (patient) via Pfizer. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 05Apr2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not re-ported. On an unspecified date in Apr2021, the patient experienced heart racing and pounding, light-headed, felt really hot after her first dose but after a few minutes it was all gone. Patient was asking if she can still take the 2nd dose. The medical questions were addressed by this program forwarded/referred to Medical Information. The outcome of events was recovered on an unspecified date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522189
Sex: F
Age:
State:

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Fever 100.1 F; Chills; Muscle aches; Sore throat; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included lamotrigine (LAMICTAL), bupropion hydrochloride (WELLBUTRIN), methylphenidate (MANUFACTURER UNKNOWN) and ethinylestradiol; ferrous fumarate; norethisterone acetate (JUNEL FE). Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 07Apr2021, the patient experienced a fever of 100.1 Fahrenheit (F), chills, muscle aches, sore throat and headache. The patient underwent a body temperature test on 07Apr2021, and the result was observed to be a temperature of 100.1 F. Therapeutic measures were not taken as a result of the events fever of 100.1 F, chills, muscle aches, sore throat and headache. The clinical outcome of the events fever of 100.1 F, chills, muscle aches, sore throat and headache was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LAMICTAL; WELLBUTRIN; METHYLPHENIDATE; JUNEL FE

Current Illness:

ID: 1522190
Sex: U
Age:
State: TX

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: heart palpitations; This is a Spontaneous report from a contactable Consumer. The contactable consumer (patient, self-reported) reported in response to the Non-HCP letter that was sent included A 18-years-old patient of unspecified gender received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9269 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 03Feb2021 at 09:30 AM (age at vaccination: 18 years), as a single dose for COVID-19 immunization at public health clinic. Vaccine was not administered at facility. The patient's medical history included Postral orthastatic tacacardia syndrome (POTS) from Jul2017 and Wilkies syndrome (pertinent details: gastric bypass). Concomitant medication included omeprazole (PRILOSEC) for heartburn. The patient did not receive any vaccine within 4 weeks prior vaccinations. On 03Feb2021 at 21:30, the patient experienced heart palpitations. The patient did not receive any treatment for the event. Outcome of the event was recovered on an unspecified date. No follow-up attempts are needed. No further information is expected.

Other Meds: PRILOSEC [OMEPRAZOLE]

Current Illness:

ID: 1522191
Sex: M
Age:
State: FL

Vax Date: 04/02/2021
Onset Date: 04/04/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Today is mild discomfort and fair to good mobility; Sciatica; The pain I experienced Sun through Tue limited my mobility significantly and I had trouble sitting and changing positions.; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 02Apr2021 at 10:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included no diagnosed illnesses and no chronic health conditions. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 07:00, the patient experienced sciatica. Sciatica was really bad on Sunday through Tuesday. The patient had never had sciatica and the pain he experienced Sunday through Tuesday limited the patient's mobility significantly and he had trouble sitting and changing positions. The patient did not know if it was coincidental but he had never had sciatica ever before. The pain was concentrated below his hip on the outside. He would occasionally have shooting pains with tingling down his leg. It was a bizarre experience. On 07Apr2021, the patient experienced mild discomfort and fair to good mobility and sciatica was much better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sciatica was really bad on Sunday through Tuesday, limited the patient's mobility significantly and he had trouble sitting and changing positions and mild discomfort was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522192
Sex: F
Age:
State: NC

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Sore neck; Sore jaw; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 07Apr2021 at 09:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included an allergy to latex powder. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, on the same day of vaccination, the patient experienced a sore neck and a sore jaw. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore neck and sore jaw were recovered on 07Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1522193
Sex: M
Age:
State: TX

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Became very hot; Skin very sensitive to touch; headache; muscle aches; very sensitive to touch and almost like a sun burn feeling; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the arm left on 06Apr2021 at 10:00(at the age of 49-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. Concomitant medications included eszopiclone (MANUFACTURER UNKNOWN, 3mg) and DESVENLAFAXINE SUCCNT ER both from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the arm left on 14Mar2021 at 17:15 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 patient experienced (Feeling hot)Became very hot, her skin (all over) was very sensitive to touch(sensitive skin) and almost like a sun burn feeling(burning skin). she also got bad headache (headache) and muscle aches (muscle ache). All of this began approx 10-12 hours after shot and lasted about 14 hours. The clinical outcome of the events became very hot, Skin very sensitive to touch, burning skin, headache and muscle aches were resolving. No follow-up attempts are needed. No further information is expected.

Other Meds: ESZOPICLONE

Current Illness:

ID: 1522194
Sex: F
Age:
State: CT

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Felt like a bad wasp/hornet sting that burned.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: LOTER2613) via an unspecified route of administration in the arm right on 01Apr2021 at 12:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included diffuse cutaneous mastocytosis, osteoarthritis and attention deficit disorder (ADD). The patient received unspecified medications within two weeks of vaccination. The patient previously took codeine on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 12:15, the patient experienced vaccination site burning from the moment the injection started, the patient felt like she was being stung by a wasp or hornet. The patient never had that sensation with any other vaccine (or needle injection of any kind). For several hours after the injection it continued to felt like a bad wasp/hornet sting that burned. The patient iced it several times. The patient had cutaneous mastocytosis. The patient saw the release from) of a study to look at mast cells in adverse reactions to the vaccines, the patient thought perhaps mastocytosis might be linked to the immediate burning session that the patient experienced and then lasted for several hours. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event injection felt like a bad wasp/hornet sting that burned (vaccination site burning) was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522195
Sex: F
Age:
State: TX

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: CHILLS FOR 5 HOURS; Loss of sleep; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 06Apr2021 at 13:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issue. The patient had no known allergies to medications, food or other products. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via unspecified route of administration in the left arm on 07Mar2021 at 12:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 06Apr2021 at 23:00, ten hours after the vaccination, the patient experienced chills for 5 hours and loss of sleep. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events chills and loss of sleep. The clinical outcome of the event chills was resolved on 07Apr2021 at 04:00 and the clinical outcome of the event loss of sleep was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522196
Sex: F
Age:
State: CA

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Sore Arm; Sore Throat; Fatigue; Nausea; Sugars running high; This is a spontaneous report from a contactable consumer. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 03Apr2021 at 16:15 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus. Concomitant medications included levofloxacin (LEVOXIN), insulin lispro (HUMALOG) and insulin glargine (LANTUS), all from an unknown start date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 13Mar2021 at 16:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 next day after the vaccine, the patient experienced sore arm, sore throat, fatigue, nausea and sugars were running high (patient type 1 diabetic). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of events sore arm, sore throat, fatigue, nausea and sugars were running high was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOXIN; HUMALOG; LANTUS

Current Illness: Type 1 diabetes mellitus

ID: 1522197
Sex: F
Age:
State: TX

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Face became itchy / Whole body became itchy; Hive in random places; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to nuts, egg, shellfish, peanut, coconut and pet dander. Concomitant medications included fluticasone (MANUFACTURER UNKNOWN) and norethidrone acetate-ethinylestradiol (MANUFACTURER UNKNOWN), both taken for unspecified indications from unknown dates. The patient previously took amoxicillin and tramadol and experienced drug allergy with both. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 11:00, about 30 minutes after the vaccination, the patient experienced that her face became itchy, over the next 3 hours her whole body became itchy, there was no visible rash and she had hives in random places (two on face, one on neck, one on back, one in armpit). Even after 9 hours the patient felt itchy. On an unknown date, the patient underwent COVID-19 test (nasal swab) and the result was negative. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events face and whole body were itchy and hives were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: FLUTICASONE; NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL

Current Illness:

ID: 1522198
Sex: F
Age:
State: CT

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Mild chills; fatigue; Mild tenderness in the armpit of my left arm.; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 06Apr2021 at 10:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome. The patient did not have any allergies to medications, food, or other products. Concomitant medications included vitamin d nos, fish oil and multi vitamins; al from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 for COVID-19 immunisation (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 09:00, the patient experienced mild chills, fatigue and mild tenderness in the armpit of left arm. The patient did not receive any treatment for the events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event's mild chills, fatigue and mild tenderness in the armpit of left arm were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Vitamin d; FISH OIL

Current Illness:

ID: 1522199
Sex: M
Age:
State: MA

Vax Date: 03/08/2021
Onset Date: 04/02/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Excessive nose bleeding from both sides. Non-stop dripping 1+drops per second for 30 minutes +/-, 3-4 episodes per day for three days. Started from day 2 after second dose.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 08Mar2021 at 16:45 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 31Mar2021 at 16:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included lower back pain and allergy to sulfonamide and pollens. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and multivitamins, all from unknown date for unknown indication taken within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021, the patient experienced excessive nose bleeding from both sides. The patient reported that it was non-stop dripping more than 1 drop per second for 30 minutes or so for 3-4 times per day for three days. This event started from day 2 after second dose. there was no irritation or any touching to trigger. The patient experienced one such episode after 1st dose and before 2nd dose and he had more than 10 episodes after the 2nd dose. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. The clinical outcome of the event nose bleeding was resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: Zyrtec

Current Illness:

ID: 1522200
Sex: F
Age:
State: GA

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Ringing in both ears; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Apr2021 at 15:45 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:45 (started 2 hours after 1 dose), the patient experienced ringing in both ears and nausea. No therapeutic measures were taken for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events ringing in both ears and nausea were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522201
Sex: F
Age:
State: AR

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: sore at injection site; sore under arm; headache; fatigue; swollen in area between collarbone and neck on side where shot was given; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in left arm on 06Apr2021 at 13:00 (at the age of 48 year-old) as single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient received other medication(unspecified) in two weeks of vaccination. The patient previously received first dose of BNT162b2(PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in left arm on 13Mar2021 at 12:00 (at the age of 48 year-old) as single dose for COVID-19 immunisation. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 06Apr2021 at 15:00, the patient experienced sore at injection site(vaccination site), sore under arm, headache, fatigue, and swollen in area between collarbone and neck on side where shot was given. The patient did not receive any treatment for the reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event sore at injection site, sore under arm, headache, fatigue, and swollen in area between collarbone and neck were not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1522202
Sex: U
Age:
State:

Vax Date: 03/20/2021
Onset Date: 03/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Third day, severe tennis elbow on right arm; One week later, tennis elbow on left arm; This is a spontaneous report from a contactable consumer, the patient. An unknown gender patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20Mar2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no allergies to to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, third day after vaccination, the patient experienced severe tennis elbow on right arm. On an unknown date in Mar2021, one week later after vaccination, the patient experienced tennis elbow on left arm. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measure was taken as a result of the reported adverse events. The clinical outcome of the event severe tennis elbow on right arm and tennis elbow on left arm were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522203
Sex: F
Age:
State: CT

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Red knuckles on hands; Itchy knuckles on hands and a bit on feet; Red and itchy feet; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 06Apr2021 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT) and fexofenadine hydrochloride (ALLEGRA), all from an unknown date for an unknown indication. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 16Mar2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced red and itchy knuckles on hands (mostly the left hand which is the side of the vaccine) and also a bit on feet. No therapeutic measures were taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events red hands, itchy and redness on legs was recovered on an unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds: SYMBICORT; ALLEGRA

Current Illness:

ID: 1522204
Sex: F
Age:
State: MA

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: dizziness; feeling unwell; low grade fever; joint pain; cloudy in head; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Box # 18) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medications 2 weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced dizziness, feeling unwell, low grade fever, joint pain and cloudy in head. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and the emergency room/department or urgent care. The clinical outcome of the events dizziness, feeling unwell, low grade fever, joint pain and foggy feeling in head were recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522205
Sex: F
Age:
State: MN

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: developed a lump above collarbone and is about the size of a nickel and is hard and immovable; It does hurt similar to a sensitive bruise; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 11:00 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history included scoliosis. Concomitant medication included MONOLINYAH started on an unknown date for birth control. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 11:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Feb2021 at 10:00, the patient experienced a lump above the collarbone(neck mass) which was about the size of a nickel and was hard and immovable and hurt similar to a sensitive bruise. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events a lump above the collarbone and hurt similar to a sensitive bruise was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522206
Sex: F
Age:
State: GA

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: High fever; Migraine headache; Achy shoulders; Achy hips; Nausea; Racing heart beat; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 16:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient has no allergies to food, medication or other products. Concomitant medications included biotin (MANUFACTURER UNKNOWN), ascorbic acid (VIT C), zinc (MANUFACTURER UNKNOWN), glucosamine (MANUFACTURER UNKNOWN) and cholecalciferol (VIT D-3) all for unknown indications from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 10:00 the patient experienced high fever, migraine head ache, achy shoulders, achy hips, nausea and racing heartbeat. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events high fever, migraine head ache, achy shoulders, achy hips, nausea and racing heartbeat were not recovered at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: BIOTIN; VIT C; ZINC; GLUCOSAMINE; Vit D-3

Current Illness:

ID: 1522207
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Lump on neck; This is a spontaneous report from a contactable consumer. A 46-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. It was unknown whether the patient had any medical history. It was unknown whether patient had any allergies to medications, food, or other products. It was unknown whether patient received any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced lump on neck. It was unknown whether any therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event of lump on neck was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522208
Sex: F
Age:
State: RI

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Chills; fever; body aches; stomach ache; Dizziness; Weakness; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 11:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had drug allergy to augmentin and sulfa drugs. Concomitant medications included escitalopram (MANUFCTURER UNKNOWN) within 2 weeks of vaccination for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 13Mar2021 at 11:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 23:30, the patient experienced chills, fever, body aches, stomach ache, dizziness, weakness and diarrhea. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event chills, fever, body aches, stomach ache, dizziness, weakness and diarrhea were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ESCITALOPRAM

Current Illness:

ID: 1522209
Sex: F
Age:
State: NJ

Vax Date: 03/01/2021
Onset Date: 04/02/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Got an unscheduled period three weeks early; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as none. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Apr2021, a week after receiving the vaccine the patient experienced an unscheduled period three weeks early. The patient had never missed period neither was late or gotten it early. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event irregular period was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522210
Sex: F
Age:
State: CT

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: The very worst of the headaches was a week after shot, with very bad total body muscle aches for one day.; Bad headaches started the next day. I have continued to have the painful headaches most of the days since getting the 1st dose of pfizer vaccine, including today, about 3 weeks later. The very worst of the headaches was a week after shot; This is a spontaneous report from a contactable consumer, the patient. An adult non-pregnant female patient of unspecified age received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6205) via an unspecified route of administration in the left arm on 18Mar2021, as a single dose for COVID-19 immunisation. The patient had no medical history and did not receive any concomitant medications. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Mar2021, the patient experienced bad headaches that started the next day. The patient continued to have the painful headaches most of the days since getting the first dose of Pfizer vaccine, including the day of reporting, about 3 weeks later. The very worst of the headaches was a week after shot, with very bad total body muscle aches for one day on 25Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the event bad headaches that started the next day was not recovered while that of very bad total body muscle aches for one day was recovered on 26Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522211
Sex: U
Age:
State: OR

Vax Date: 03/20/2021
Onset Date: 04/02/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Fever; loss of appetite; No other symptoms other than loss of appetite and weariness.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old patient of unknown gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 10:15 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. The patient had no reported allergies to medication, food or other products but could be sensitive to drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:00 the patient experienced fever that lasted until early morning of 05Apr2021. Fever ran as high as 102 degrees Fahrenheit, never dropping below 101 through 04Apr2021. No other symptoms other than loss of appetite and weariness were reported. The events resulted in doctor or other healthcare professional office/clinic visit. On 05Apr2021, the patient underwent lab tests which included nasal swab and the result was negative. No therapeutic measures were taken as a result of the events. The clinical outcome of the event fever was recovered on 05Apr2021 while the events loss of appetite and weariness were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1522212
Sex: M
Age:
State: NJ

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Pronounced headache; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 09:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 09:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 11:15, approximately two hours after second dose of injection, the patient experienced pronounced headache. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event pronounced headache was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522213
Sex: M
Age:
State: NY

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: quite a bit of muscular or joint pain in the area where he received the shot; no desires to go outside; Light Sensitivity; fatigued; loss of appetite; couldn't move; malaise; dizzy; joint pain; left toe was numb,; left knee cap hurt, was twitching and tight; headache; burning, irritation, tingling at injection site; burning, irritation, tingling at injection site; burning, irritation, tingling at injection site; flushed face throughout the day, almost like a sunburn; This is a spontaneous report from a contactable consumer (patient) or other non health care professional. A 53-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection Lot Number: ER8730), dose 2 via an unspecified route of administration, administered in Arm Right on 31Mar2021 (Age at vaccination: 53 years) as dose 2, single for covid-19 immunisation. Medical history included ongoing lyme disease he was 45 years old when he was diagnosed, autoimmune disorder from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced burning, irritation, tingling at injection site, flushed face throughout the day, almost like a sunburn and headache on 31Mar2021. He had quite a bit of muscular or joint pain in the area where he received the shot, no desires to go outside, light sensitivity, fatigued, loss of appetite , couldn't move, malaise, dizzy, joint pain, left toe was numb, left knee cap hurt, was twitching and tight on an unknown date. Reporetr states he just wanted to, for information purposes, review what he went through post- vaccination especially because he has Lyme disease. He has had this pre-existing autoimmune disease for 8, almost 9 years, he wants to add this information to Pfizer's database. Reporetr states the second shot, he showed up at the vaccination place locally and they actually declined his ability to get it with them because of his first reaction even though he had the go ahead from his Lyme specialist and primary doctors. Caller states because of this, he went after four weeks instead of three and he went to a high risk clinic to protect him from anaphylaxis. Reporter states no reaction whatsoever with the second, though he still has remaining symptoms. He states he has written that he has the sensation of ants crawling over the top of his back, no desires to go outside, and light sensitivity. Caller verifies the ants crawling over the top of his back was also neuropathy, and he recovered completely within 3 weeks. Light Sensitivity: reporter states throughout the whole thing, had it today and was still ongoing and persisting. He states began sometime in MAR2021, its been the whole time. He states 28 MAR 2021, he only slept 6 hours and woke up completely fatigued, could not get out of bed until 2:00 in the afternoon, has a complete loss of appetite, had a drink and 2 eggs and laid down, couldn't move until 1930. He states got up, had a nutrition shake, he wasn't desiring solid foods whatsoever, had 100% malaise, fatigue, no appetite, and was dizzy. Loss of appetite: states he has lost 7 pounds since the first shot. he wasn't really interested in eating. he has a natural desire to eat and nothing sounded good. He started in MAR2021, was ongoing, and has improved. He states 31MAR2021, he got the second shot, he had a little bit of irritation, tingling and burning at site and definitely a flushed face throughout the day, almost like a sunburn. he was joking with clients and said the first shot killed him and the second shot cured him. after the second shot, he was 80% better but can list the remaining symptoms. He states what he was left with is fatigue, he does not have any energy to do anything other than work, sleep issues, neuropathy, and dizziness. Dizziness: He states the dizziness has been consistent and goes with the sleeplessness, ongoing since MAR2021 and was persisting. Irritation, tingling, and burning at injection site: Reporter verifies the irritation, tingling, and burning is at the injection site of the second dose. He states it happened within a few hours on 31MAR2021 and resolved within a week on or around 07APR2021. states the good news was he was great, everything looked normal, there was nothing crazy in the blood work. Caller states they though the shots would have triggered an autoimmune response of Lyme. Muscle/Joint: He reports a bit of muscular/joint pain in the area where the shot is, if he goes to reac. The outcome of the events flushed face throughout the day, almost like a sunburn, quite a bit of mus-cular or joint pain in the area where he received the shot, no desires to go outside, Light Sensitivity, fatigued, loss of appetite, couldn't move, malaise, dizzy, joint pain, left toe was numb, left knee cap hurt, was twitching and tight was unknown and of the event burning, irritation, tingling at injection site, headache was recovered on 07April2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Lyme disease (he was 45 years old when he was diagnosed)

ID: 1522214
Sex: M
Age:
State: IL

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: started to have chest pain and shortness of breath- irregular heartbeat and "blood pressure was all over the place; started to have chest pain and shortness of breath- irregular heartbeat and "blood pressure was all over the place; chills and fatigue; chills and fatigue; started to have chest pain and shortness of breath- irregular heartbeat and "blood pressure was all over the place; started to have chest pain and shortness of breath- irregular heartbeat and "blood pressure was all over the place; This is a spontaneous report from a contactable consumer. This consumer (patient) reported himself that a 37-years-old male patient received second dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, lot/Batch: EN6207), via intramuscular route of administration in left arm on 20Apr2021 at 12:15 (at the age of vaccination 37-years-old) as single dose for COVID-19 immunisation on workplace clinic. The patient's medical history included spleen ruptured when he was 18. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, lot/Batch: EN5318), via Intramuscular route of administration in left arm on 03Mar2021 at 12:15 as historical vaccination single dose for COVID-19 immunisation. On 21April21 at 03:00, the patient started to have chest pain and shortness of breath- irregular heartbeat and "blood pressure was all over the place", had chills and fatigue. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested for COVID-19. No treatment received for adverse event. The outcome of the adverse event was recovered on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1522215
Sex: M
Age:
State: CT

Vax Date: 03/13/2021
Onset Date: 03/13/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 72-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: ENG206 and expiration date was not reported), first dose via an unspecified route of administration, administered in Arm Left on 13Mar2021 (at the age of 72 years) as single for covid-19 immunisation. Medical history included ongoing drug hypersensitivity and states he was diagnosed about 25 years ago. Family history was none reported. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Additional Vaccines Administered on Same Date of the Pfizer Suspect was None. On 13Mar2021 the patient States that within 2 minutes of receiving the Covid Vaccine, he was sitting down, and his forehead became very wet and cold and States his left side became numb and it is not as bad, but it happens at least two times a week and his blood pressure dropped. This was his first dose of the Covid Vaccine and the doctor suggested for him not to take the second dose. Adverse Event(s) did not require a visit to Emergency Room but did require Physician Office visit. The outcome of the event His left side became numb was not recovered, while the outcome of the rest of the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Penicillin allergy (States he was diagnosed about 25 years ago.)

ID: 1522216
Sex: F
Age:
State: NY

Vax Date: 04/06/2021
Onset Date: 04/08/2021
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: tested positive for COVID-19 2 days after my first dose of the vaccine; This is a spontaneous report from a contactable consumer (patient). A 23-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and Expiration date was unknown) via an unspecified route of administration on 06Apr2021 (at the age of 23-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was none. The patient concomitant medications in two weeks included fluoxetine (FLUOXETINE) taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. Other vaccines in four weeks prior to vaccination was none. The patient reported that, tested positive for covid-19 2 days after my first dose of the vaccine on 08Apr2021. The patient underwent lab tests and procedures which included sars-cov-2 test that was positive on 08Apr2021. Patient reported that, she tested positive for COVID-19 2 days after her first dose of the vaccine on 06Apr2021 after experiencing what she believed were side effects. The patient underwent lab tests and procedures which included SARS-CoV-2 test; Positive on 08Apr2021. The outcome of event tested positive for COVID-19 2 days after my first dose of the vaccine was unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained.

Other Meds: FLUOXETINE

Current Illness:

ID: 1522217
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 08/03/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: stomach flu; diarrhea.; no appetite; nausea; Sore arm; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced stomach flu, diarrhea, no appetite, nausea and sore arm on an unspecified. It was reported that patient was due to receive her second dose of COVID vaccine on 06May2021. She has been having symptoms of what she believes to be a stomach flu for the past 1-2 weeks. Patient reported that symptoms were "off-and-on" over the time period and included diarrhea and no appetite. She was asking if she should still receive her second dose as scheduled. Patient did not attribute symptoms to her first dose of vaccine, she noted that she did fine with the first shot and only reported a sore arm. Patient was not thinking her symptoms and the first dose of vaccine are related. The patient would like to speak to the nurse who would be administering the shot. The patient had previous stomach virus with diarrhea and nausea and stuff like that and has had it for the past week. She wanted to know would this bring any more harm to her by getting second shot. Outcome of event stomach flu and diarrhea was not resolved. Outcome of remining events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the temporal relationship, the association between the events stomach flu, diarrhea, no appetite, and nausea with BNT162b2 can not be fully excluded. There is a reasonable possibility that the event sore arm was related to BNT162b2 based on known drug safety profile. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm